Gefitinib and anaemia 
Gefitinib and anaemia Patient Reports February 12, 2012
Gefitinib Side Effects Report #4920025-7
Gefitinib side effect was reported by a Physician from UNITED KINGDOM on July 20, 2005. Male patient, weighting 133.2 lb, was diagnosed with non-small cell lung cancer, analgesic effect, depression
, insomnia, pain , muscle spasms and was treated with Gefitinib. After drug was administered, patient experienced the following side effects: anaemia, diarrhoea, disease progression, intestinal obstruction, liver function test abnormal, oral intake reduced, pain , renal failure, somnolence. Gefitinib dosage: unknown. During the same period patient was treated with GABAPENTIN, ACETAMINOPHEN, CARBAMAZEPINE, VENLAFAXINE, CLONAZEPAM, HALOPERIDOL, BUSCOPAN. Patient was hospitalized. Patient recovered.Gefitinib Side Effects Report #4928992-2
Gefitinib side effect was reported by a Physician from UNITED KINGDOM on July 20, 2005. Male patient, weighting 133.2 lb, was diagnosed with non-small cell lung cancer, analgesic effect, depression
, insomnia, pain , muscle spasms and was treated with Gefitinib. After drug was administered, patient experienced the following side effects: anaemia, diarrhoea, intestinal obstruction, liver function test abnormal, malignant neoplasm progression, non-small cell lung cancer, overgrowth bacterial, pain , pancreatic insufficiency. Gefitinib dosage: unknown. During the same period patient was treated with GABAPENTIN, ACETAMINOPHEN, CARBAMAZEPINE, VENLAFAXINE, CLONAZEPAM, HALOPERIDOL, BUSCOPAN. Patient was hospitalized. Patient recovered.Gefitinib Side Effects Report #4941031-2
Gefitinib side effect was reported by a Physician from UNITED KINGDOM on July 20, 2005. Male patient, weighting 133.2 lb, was diagnosed with non-small cell lung cancer, analgesic effect, depression
, insomnia, pain , muscle spasms and was treated with Gefitinib. After drug was administered, patient experienced the following side effects: anaemia, diarrhoea, intestinal obstruction, liver function test abnormal, malignant neoplasm progression, non-small cell lung cancer, oral intake reduced, overgrowth bacterial, pain . Gefitinib dosage: unknown. During the same period patient was treated with GABAPENTIN, ACETAMINOPHEN, CARBAMAZEPINE, VENLAFAXINE, CLONAZEPAM, HALOPERIDOL, BUSCOPAN. Patient was hospitalized. Patient recovered.Gefitinib Side Effects Report #4951438-5
Gefitinib side effect was reported by a Physician from UNITED KINGDOM on July 20, 2005. Male patient, weighting 133.2 lb, was diagnosed with non-small cell lung cancer, analgesic effect, depression
, insomnia, pain , muscle spasms and was treated with Gefitinib. After drug was administered, patient experienced the following side effects: anaemia, diarrhoea, disease progression, intestinal obstruction, liver function test abnormal, overgrowth bacterial, pancreatic insufficiency, renal failure, somnolence. Gefitinib dosage: unknown. During the same period patient was treated with GABAPENTIN, ACETAMINOPHEN, CARBAMAZEPINE, VENLAFAXINE, CLONAZEPAM, HALOPERIDOL, BUSCOPAN. Patient was hospitalized. Patient recovered.Gefitinib Side Effects Report #4585328-7
Gefitinib side effect was reported by a Physician from on Feb 02, 2005. Female patient, 56 years of age, weighting 171.5 lb, was diagnosed with glioma, recurrent cancer, malignant melanoma and was treated with Gefitinib. After drug was administered, patient experienced the following side effects: anaemia, blood osmolarity decreased, bone lesion, condition aggravated, dehydration, depressed level of consciousness, diabetes mellitus, diarrhoea, eating disorder
. Gefitinib dosage: 500 MG QD PO. During the same period patient was treated with RAPAMUNE. Patient was hospitalized. Patient recovered.Gefitinib Side Effects Report #4578403-4
Gefitinib side effect was reported by a Health Professional from on Feb 03, 2005. Female patient, weighting 170.9 lb, was diagnosed with glioblastoma multiforme and was treated with Gefitinib. After drug was administered, patient experienced the following side effects: anaemia, convulsion, diarrhoea, electroencephalogram abnormal, hypokalaemia, thrombocytopenia, urinary tract infection
, vomiting. Gefitinib dosage: 250 MG PO, QD. During the same period patient was treated with RAPAMUNE, DEPAKOTE, DECADRON, ALBUTEROL PRN. Patient was hospitalized. Patient recovered.